-+ 0.00%
-+ 0.00%
-+ 0.00%

INTELLIA THERAPEUTICS ANNOUNCES FDA ACCEPTANCE OF BIOLOGICS LICENSE APPLICATION WITH PRIORITY REVIEW FOR LONVOGURAN ZICLUMERAN (LONVO-Z) FOR HEREDITARY ANGIOEDEMA (HAE)

路透·09/08/2026 12:00:04

登录查看新闻详情